3 out of 4 commercially insured patients on mealtime insulin have coverage for the Dexcom G6 Continuous Glucose Monitoring (CGM) System
Zero fingersticks* or scanning required.
Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.
Includes a predictive Urgent Low Soon alert and a suite of customizable high and low glucose alerts.
* If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
92% of surveyed US patients said that Dexcom G6 is easy to use.
This post is related to:Revenue Stream Opportunities